000 | 01840 a2200493 4500 | ||
---|---|---|---|
005 | 20250515153529.0 | ||
264 | 0 | _c20090526 | |
008 | 200905s 0 0 eng d | ||
022 | _a1120-6721 | ||
024 | 7 |
_a10.1177/112067210901900127 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTuncer, S | |
245 | 0 | 0 |
_aPolypoidal choroidal vasculopathy following photodynamic therapy for choroidal hemangioma. _h[electronic resource] |
260 |
_bEuropean journal of ophthalmology _c |
||
300 |
_a159-62 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAngiogenesis Inhibitors _xtherapeutic use |
650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
650 | 0 | 4 | _aBevacizumab |
650 | 0 | 4 |
_aChoroid _xblood supply |
650 | 0 | 4 |
_aChoroid Diseases _xchemically induced |
650 | 0 | 4 |
_aChoroid Neoplasms _xdrug therapy |
650 | 0 | 4 | _aColoring Agents |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFluorescein Angiography |
650 | 0 | 4 |
_aHemangioma _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIndocyanine Green |
650 | 0 | 4 |
_aIschemia _xchemically induced |
650 | 0 | 4 |
_aMacular Edema _xchemically induced |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aPeripheral Vascular Diseases _xchemically induced |
650 | 0 | 4 |
_aPhotochemotherapy _xadverse effects |
650 | 0 | 4 |
_aPhotosensitizing Agents _xadverse effects |
650 | 0 | 4 |
_aPorphyrins _xadverse effects |
650 | 0 | 4 |
_aVascular Endothelial Growth Factor A _xantagonists & inhibitors |
650 | 0 | 4 | _aVerteporfin |
700 | 1 | _aDemirci, H | |
700 | 1 | _aShields, C L | |
700 | 1 | _aShields, J A | |
773 | 0 |
_tEuropean journal of ophthalmology _gvol. 19 _gno. 1 _gp. 159-62 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1177/112067210901900127 _zAvailable from publisher's website |
999 |
_c18572710 _d18572710 |